Last reviewed · How we verify

NCT03293979

Alere i FluA*B Biologic Test Relocated in Emergency Service for Flu Diagnosis

Completed Last updated 9 August 2018
What this trial tests

trial testing Test A i Flu A&B implemented in emergency service in Flu in 301 participants. Completed in 30 June 2018.

Timeline
22 January 2016
Primary endpoint
31 December 2016
30 June 2018

Quick facts

Lead sponsorFondation Hôpital Saint-Joseph
StatusCompleted
Study typeOBSERVATIONAL
Enrollment301
Start date22 January 2016
Primary completion31 December 2016
Estimated completion30 June 2018
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Fondation Hôpital Saint-Joseph — full company profile →

Who can join

18 and older, any sex, with Flu. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

It appears that the heavyness of flu pathology, the diagnosis limits and the validity of it was well studied in the last years.However, the economical impact and the organisation benefit in emergency service is not yet evaluated Our purpose is to study the impact of implementation of fast flu diagnosis by molecular biology available in emergency service in the economic field .

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Flu

Currently open trials in the same condition.

Other Fondation Hôpital Saint-Joseph trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03293979.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing